Nutrition interventions in congenital disorders of glycosylation.

Trends Mol Med

Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA. Electronic address:

Published: June 2022

Congenital disorders of glycosylation (CDG) are a group of more than 160 inborn errors of metabolism affecting multiple pathways of protein and lipid glycosylation. Patients present with a wide range of symptoms and therapies are only available for very few subtypes. Specific nutritional treatment options for certain CDG types include oral supplementation of monosaccharide sugars, manganese, uridine, or pyridoxine. Additional management includes specific diets (i.e., complex carbohydrate or ketogenic diet), iron supplementation, and albumin infusions. We review the dietary management in CDG with a focus on two subgroups: N-linked glycosylation defects and GPI-anchor disorders.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375550PMC
http://dx.doi.org/10.1016/j.molmed.2022.04.003DOI Listing

Publication Analysis

Top Keywords

congenital disorders
8
disorders glycosylation
8
nutrition interventions
4
interventions congenital
4
glycosylation
4
glycosylation congenital
4
glycosylation cdg
4
cdg group
4
group 160
4
160 inborn
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!